Mammographic density: Potential as a risk factor and surrogate marker in the clinical setting

Current Breast Cancer Reports

Volumn 5, Issue 3, 2013, Pages 183-193

  Vachon, Celine M ^a   Ghosh, Karthik ^a   Brandt, Kathleen R ^b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

BI RADS; Breast cancer; Breast density; Dense breasts; Risk factor; Risk prediction; Supplemental screening

Indexed keywords

AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; PLACEBO; PROGESTERONE RECEPTOR; RALOXIFENE; TAMOXIFEN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; BREAST SURGERY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMENOPAUSE; PREVALENCE; QUANTITATIVE DIAGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE;

EID: 84884356841     PISSN: 19434588     EISSN: 19434596     Source Type: Journal    
DOI: 10.1007/s12609-013-0118-8     Document Type: Article

References (112)

1. Kerlikowske K, Cook AJ, Buist DS, et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28:3830-7.
2. McCormack VA, dos Santos SI. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:1159-69.
3. Heine JJ, Scott CG, Sellers TA, et al. A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst. 2012;104:1028-37.
4. Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev. 2003;12:332-8. (Pubitemid 36427994)
5. Maskarinec G, Meng L. A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000;63:153-61.
6. Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101:384-98.
7. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36. (Pubitemid 46143226)
8. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87:1622-9.
9. Olson JE, Sellers TA, Scott CG, et al. The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort. Breast Cancer Res. 2012;14:R147.
10. Vachon CM, Brandt KR, Ghosh K, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomark Prev. 2007;16:43-9. (Pubitemid 46174262)
11. Vachon CM, van Gils CH, Sellers TA, et al. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007;9:217.
12. Provenzano PP, Inman DR, Eliceiri KW, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6:11.
13. Ghosh K, Hartmann LC, Reynolds C, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010;28:2207-12.
14. Vachon CM, Sasano H, Ghosh K, et al. Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat. 2011;125:243-52.
15. McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst. 2005;97:1366-76. (Pubitemid 41487804)
16. Cuzick J, Warwick J, Pinney E, et al. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004;96:621-8. (Pubitemid 38584986)
17. Son HJ, Oh KK. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery. Am J Roentgenol. 1999;173:905-9.
18. Brisson J, Brisson B, Cote G, et al. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomark Prev. 2000;9:911-5.
19. Smith J, Dilawari A, Ursin G, et al. A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density. Anticancer Res. 2012;32:1327-31.
20. Prowell TM, Blackford AL, Byrne C, et al. Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole. Cancer Prev Res. 2011;4:1993-2001.
21. Kim J, Han W, Moon HG, et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res. 2012;14:R102.
22. Mousa NA, Crystal P, Wolfman WL, et al. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause. 2008;15:875-84.
23. Cuzick J, Warwick J, Pinney E, et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst. 2011;103:744-52.
24. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-75. (Pubitemid 36231622)
25. Habel LA, Dignam JJ, Land SR, et al. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004;96:1467-72. (Pubitemid 39429671)
26. Habel LA, Capra AM, Achacoso NS, et al. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2010;19:2488-95.
27. Hwang ES, Miglioretti DL, Ballard-Barbash R, et al. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007;16:2587-93 (Pubitemid 351196313)
28. Cil T, Fishell E, Hanna W, et al. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer. 2009;115:5780-7.
29. Park CC, Rembert J, Chew K, et al. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009;73:75-9.
30. Boyd NF, Lockwood GA, Byng JW, et al. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7:1133-44. (Pubitemid 29001671)
31. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993;15:196-208. (Pubitemid 23269083)
32. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976;37:2486-92.
33. Gram IT, Funkhouser E, Tabar L. The Tabar classification of mammographic parenchymal patterns. Eur J Radiol. 1997;24:131-6. (Pubitemid 27165353)
34. Shepherd JA, Kerlikowske K, Ma L, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2011;20:1473-82.
35. Heine JJ, Carston MJ, Scott CG, et al. An automated approach for estimation of breast density. Cancer Epidemiol Biomark Prev. 2008;17:3090-7.
36. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87:670-5.
37. Byng JW, Boyd NF, Fishell E, et al. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39:1629-38. (Pubitemid 24306719)
38. Breast Cancer Surveillance Consortium. NCI-funded Breast Cancer Surveillance Consortium (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C). Downloaded from the Breast Cancer Surveillance Consortium website - http://breastscreening. cancer.gov/data/variables/.
39. Kerlikowske K, Ichikawa L, Miglioretti DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst. 2007;99:386-95. (Pubitemid 47073482)
40. American College of Radiology. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
41. Ciatto S, Houssami N, Apruzzese A, et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast. 2005;14:269-75. (Pubitemid 41110187)
42. Kerlikowske K, Grady D, Barclay J, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst. 1998;90:1801-9. (Pubitemid 28559892)
43. Li J, Szekely L, Eriksson L, et al. High-throughput mammographic density measurement: a tool for risk prediction of breast cancer. Breast Cancer Res. 2012;14:R114.
44. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital vs film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773-83. (Pubitemid 41549889)
45. Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital vs film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155:493-502.
46. Vachon CM, Fowler EE, Tiffenberg G, et al. Comparison of percent density from raw and processed full-field digital mammography data. Breast Cancer Res. 2013;15:R1.
47. Harvey JA, Gard CC, Miglioretti DL, et al. Reported mammographic density: film-screen vs digital acquisition. Radiology. 2013;266:752-8.
48. Heine JJ, Fowler EE, Flowers CI. Full field digital mammography and breast density: comparison of calibrated and noncalibrated measurements. Acad Radiol. 2011;18:1430-6.
49. Heine JJ, Cao K, Rollison DE, et al. A quantitative description of the percentage of breast density measurement using full-field digital mammography. Acad Radiol. 2011;18:556-64.
50. Ciatto S, Bernardi D, Calabrese M, et al. A first evaluation of breast radiological density assessment by QUANTRA software as compared with visual classification. Breast. 2012;21:503-6.
51. Skippage P, Wilkinson L, Allen S, et al. Correlation of age and HRT use with breast density as assessed by Quantra. Breast J. 2013;19:79-86.
52. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13:223.
53. Brisson J, Morrison AS, Khalid N. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project. J Natl Cancer Inst. 1988;80:1534-40. (Pubitemid 19009649)
54. Pollan M, Ascunce N, Ederra M, et al. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res. 2013;15:R9.
55. Yaghjyan L, Colditz GA, Collins LC, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103:1179-89.
56. Antoni S, Sasco AJ, dos Santos SI, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137:337-47.
57. Phipps AI, Li CI, Kerlikowske K, et al. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomark Prev. 2010;19:1643-54.
58. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-52.
59. Phipps AI, Buist DS, Malone KE, et al. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012;22:340-8.
60. Ma H, Luo J, Press MF, et al. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomark Prev. 2009;18:479-85.
61. Eriksson L, Hall P, Czene K, et al. Mammographic density and molecular subtypes of breast cancer. Br J Cancer. 2012;107:18-23.
62. Ziv E, Tice J, Smith-Bindman R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomark Prev. 2004;13:2090-5. (Pubitemid 40054303)
63. Eriksson L, Czene K, Rosenberg L, et al. The influence of mammographic density on breast tumor characteristics. Breast Cancer Res Treat. 2012;134:859-66.
64. Hinton CP, Roebuck EJ, Williams MR, et al. Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer. Am J Roentgenol. 1985;144:1103-7. (Pubitemid 15000385)
65. Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol. 2011;35:448-52.
66. Heusinger K, Jud SM, Haberle L, et al. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer. 2012;131:2643-9.
67. Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405-10.
68. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86. (Pubitemid 20026073)
69. Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93:358-66. (Pubitemid 32229380)
70. Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006;98:1215-26. (Pubitemid 44390992)
71. Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006;98:1204-14. (Pubitemid 44390991)
72. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat. 2005;94:115-22. (Pubitemid 41547108)
73. Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148:337-47. (Pubitemid 351665464)
74. Darabi H, Czene K, Zhao W, et al. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14:R25.
75. Porter GJ, Evans AJ, Cornford EJ, et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. Am J Roentgenol. 2007;188:676-83.
76. van Gils CH, Otten JD, Verbeek AL, et al. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen The Netherlands. J Epidemiol Community Health. 1998;52:267-71. (Pubitemid 28176825)
77. Olsen AH, Bihrmann K, Jensen MB, et al. Breast density and outcome of mammography screening: a cohort study. Br J Cancer. 2009;100:1205-8.
78. Gierach GL, Ichikawa L, Kerlikowske K, et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2012;104:1218-27.
79. Maskarinec G, Pagano IS, Little MA, et al. Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort. Breast Cancer Res. 2013;15:R7.
80. Chiu SY, Duffy S, Yen AM, et al. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomark Prev. 2010;19:1219-28.
81. Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomark Prev. 2006;15:732-9.
82. Kelemen LE, Pankratz VS, Sellers TA, et al. Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Am J Epidemiol. 2008;167:1027-36. (Pubitemid 351601250)
83. Boyd N, Martin L, Stone J, et al. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomark Prev. 2002;11:1048-53. (Pubitemid 35192656)
84. Henson D, Tarone R. On the possible role of involution in the natural history of breast cancer. Cancer 1993;71S:2154-2156. (Pubitemid 23070683)
85. van Gils CH, Hendriks JH, Holland R, et al. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev. 1999;8:509-15. (Pubitemid 30019690)
86. Vachon CM, Pankratz VS, Scott CG, et al. Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomark Prev. 2007;16:921-8. (Pubitemid 46910093)
87. Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999;130:262-9. (Pubitemid 29091853)
88. Rutter CM, Mandelson MT, Laya MB, et al. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001;285:171-6. (Pubitemid 32048518)
89. McTiernan A, Chlebowski RT, Martin C, et al. Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol. 2009;27:6135-43.
90. Vachon CM, Suman V, Brandt KR, et al. Mammographic breast density response to aromatase inhibition. Clin Cancer Res. 2013;in press. [Epub ahead of print].
91. Pearman L, Kagan R, Arsenault J, Muram D. The effects of raloxifene on mammographic breast density: a review of clinical trials. Menopause. 2010;17:654-9.
92. Eng-Wong J, Orzano-Birgani J, Chow CK, et al. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomark Prev. 2008;17:1696-701.
93. Boyd NF. Tamoxifen, mammographic density, and breast cancer prevention. J Natl Cancer Inst. 2011;103:704-5.
94. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. (Pubitemid 34977137)
95. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151-63. (Pubitemid 351679706)
96. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081-7. (Pubitemid 30616482)
97. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165-75.
98. Buist DS, Porter PL, Lehman C, et al. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst. 2004;96:1432-40. (Pubitemid 39429667)
99. Ma L, Fishell E, Wright B, et al. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst. 1992;84:781-5.
100. Hubbard RA, Kerlikowske K, Flowers CI, et al. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-92.
101. Rafferty EA, Park JM, Philpotts LE, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology. 2013;266:104-13.
102. Skaane P, Bandos AI, Gullien R, et al. Comparison of Digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47-56.
103. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221:641-9. (Pubitemid 33101754)
104. Hooley RJ, Greenberg KL, Stackhouse RM, et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology. 2012;265:59-69.
105. Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol. 2010;20:734-42.
106. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307:1394-404.
107. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-37.
108. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898-905. (Pubitemid 40563263)
109. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-25. (Pubitemid 39223222)
110. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89. (Pubitemid 46535708)
111. Rhodes DJ, Hruska CB, Phillips SW, et al. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011;258:106-18.
112. Brem RF, Rapelyea JA, Zisman G, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology. 2005;237:274-80. (Pubitemid 41346174)